Skip to main content


We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities:


Barend Mons

Good discussion (just landed from Nairobi, so was a bit out of the loop.
Also there, access rights e.d. were a hot discussion topic.
I concur with Maggie that the ‘A’ and part of R is implicitly requiring access rights and licensing (the machine need to know what it is technically able to do with the data as well as what it is ‘allowed’ to do). To me this is all covered by the generic principle of rich, machine actionable metadata for all FAIR digital objects. Measuring can imho include any further specification of that, and again, the requirements may vary per disciploine as we stated at the meeting.
I know for instance from an earlier IMI project (Open PHACTS) that the pharma is unlikely to even ‘touch’ a data set without a clear license, even if the researcher is so ‘open minded’ that putting a license did not even occur to her/him…
Prof. Barend Mons
Leiden University Medical Center
President of CODATA
GO FAIR international Support and coordination office
Mail: ***@***.***
ORCID: 0000-0003-3934-0072
sent from my IPad